new glp 1 meds Understanding GLP-1 medications Professor Receives Grant to Study

Various biomarkers are not all equivalent and have differential value for disease diagnosis and drug development

As GLP-1 has been implicated as a mediator in the putative gutrenal axis (a rapid-acting feed-forward loop that regulates postprandial fluid and electrolyte homeostasis), direct actions on the kidney have been proposed

The company expanded into heart health in August and weight management at the year of the year

Other individuals although this is in its infancy are trying to identify phenotypes when it comes to treatment: like what are the characteristics of that individual that are more likely to have them respond to a GLP-1 medication versus let's say an older oral medication